On January 30, 2015, the FDA approved the use of Vyvanse (lisdexamfetamine dimesylate) to treat binge-eating disorder (BED) in adults. This is the first medication ever approved by the FDA for the treatment of BED. But before you run out to your nearest physician to get your prescription, here are some things to know:
My opinion: I think that we need more long-term studies to really know the effectiveness and safety of Vyvanse in the treatment of BED. In the meantime, we have research-based effective psychotherapy treatments for BED (like Mindful Eating), which don’t have the risks of side-effects that medications carry.
*This article is not intended as medical advice. As always, you should consult with your physician to discuss any concerns about your health and medication.
McElroy S., Hudson J., Mitchell J., et al. Efficacy and Safety of Lisdexamfetamine for Treatment of Adults with Moderate to Severe Binge-Eating Disorder. A Randomized Clinical Trial. JAMA Psychiatry. Published Online 1/14/15
To learn more about Dr. Conason and Mindful Eating, please visit www.drconason.com